Pinney & Scofield »

Crispr Therapeutics shares owned by Pinney & Scofield

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Pinney & Scofield from 13F filings

Historical chart of Pinney & Scofield investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Pinney & Scofield consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Pinney & Scofield

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6k 75 47.57

More positions owned by Pinney & Scofield

Dimensional Etf Trust Inflation Prote (DFIP)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Real Estate E (DFAR)
Dimensional Etf Trust Intl Small Cap V (DISV)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Dimensional Etf Trust Intl Small Cap E (DFIS)
Dimensional Etf Trust Intl High Profit (DIHP)
NVIDIA Corporation (NVDA)
Vanguard Bd Index Fds Long Term Bond (BLV)

View all positions for Pinney & Scofield

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
T. Rowe Price Investment Management
Geode Capital Management
Vanguard Group
Susquehanna International
Sr One Capital Management
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Two Sigma Investments

View all funds holding Crispr Therapeutics